Amazon has revealed plans to cut as many as 14,000 corporate jobs. According to reports, the cuts will include roles in human ...

With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company has ...

Overview of Whole Genome Synthesis MarketThe global Whole Genome Synthesis Market is valued at USD 2.41 Billion in 2024 and is projected to reach a value of USD 12.21 Billion by 2035 at a CAGR ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

LinkedIn co-founder Reid Hoffman warns that Silicon Valley's software obsession is limiting AI opportunities in healthcare ...

Colorectal cancer (CRC) remains one of the most prevalent cancers worldwide and a leading cause of cancer mortality. Despite ...

docker run -p 3000:3000 \ -e NUXT_PUBLIC_SERVER_MODE=true \ -e NUXT_AI_API_KEY=your-ai-api-key \ -e NUXT_WEB_SEARCH_API_KEY=your-search-api-key \ -e NUXT_PUBLIC_AI ...

Importantly, the researchers at Boston Children's Hospital utilized the Nabsys OhmX Platform to identify a ...

Since 2019, MIT researchers have published a new concept called prime editing, which is more precise than regular CRISPR-Cas9 gene editing. As a result, it has fewer off-target effects and less chance ...

Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic ...

Robust efficacy data: ≥90% LDL-C reduction in non-human primates achieved within 48 hours of a single dose of EDIT-401; ≥90% LDL-C reduction in mice with high baseline LDL-C and reduced LDLR function ...